These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2530790)

  • 21. Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
    Schlake HP; Kuhs H; Rolf LH; Bosse T; Schuhknecht E; Rudolf GA; Brune GG
    Acta Psychiatr Scand Suppl; 1989; 350():149-51. PubMed ID: 2530775
    [No Abstract]   [Full Text] [Related]  

  • 22. A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients.
    Bascara L
    Acta Psychiatr Scand Suppl; 1989; 350():141-2. PubMed ID: 2530771
    [No Abstract]   [Full Text] [Related]  

  • 23. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
    Kuhs H; Rudolf GA
    Acta Psychiatr Scand Suppl; 1989; 350():145-6. PubMed ID: 2530773
    [No Abstract]   [Full Text] [Related]  

  • 24. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities.
    Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; See WR
    Sleep; 1991 Oct; 14(5):439-47. PubMed ID: 1836894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative acute toxicity of paroxetine and other antidepressants.
    Kelvin AS; Hakansson S
    Acta Psychiatr Scand Suppl; 1989; 350():31-3. PubMed ID: 2530781
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunological studies on paroxetine, a novel anti-depressant drug.
    Henderson DC; Edwards RG; Weston BJ; Dewdney JM
    Int J Immunopharmacol; 1988; 10(4):361-7. PubMed ID: 2971630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some quantitative EEG findings in unmedicated and medicated major depressives.
    Shagass C; Roemer RA; Josiassen RC
    Neuropsychobiology; 1988; 19(4):169-75. PubMed ID: 2907777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of paroxetine, a newly developed antidepressant, in anesthetized dogs in comparison with those of imipramine, amitriptyline and clomipramine.
    Yokota S; Ishikura Y; Ono H
    Jpn J Pharmacol; 1987 Nov; 45(3):335-42. PubMed ID: 2963926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic pathway of paroxetine in animals and man and the comparative pharmacological properties of its metabolites.
    Haddock RE; Johnson AM; Langley PF; Nelson DR; Pope JA; Thomas DR; Woods FR
    Acta Psychiatr Scand Suppl; 1989; 350():24-6. PubMed ID: 2530779
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
    Kuhs H; Schlake HP; Rolf LH; Rudolf GA
    Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of paroxetine, a selective 5-hydroxytryptamine uptake inhibitor, on beta-adrenoceptors in rat brain: autoradiographic and functional studies.
    Nelson DR; Pratt GD; Palmer KJ; Johnson AM; Bowery NG
    Neuropharmacology; 1991 Jun; 30(6):607-16. PubMed ID: 1681445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.
    Thomas DR; Nelson DR; Johnson AM
    Psychopharmacology (Berl); 1987; 93(2):193-200. PubMed ID: 2962217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
    Byrne MM
    Acta Psychiatr Scand Suppl; 1989; 350():138-9. PubMed ID: 2530768
    [No Abstract]   [Full Text] [Related]  

  • 34. An interim overview of the safety and tolerability of paroxetine.
    Dunbar GC
    Acta Psychiatr Scand Suppl; 1989; 350():135-7. PubMed ID: 2530767
    [No Abstract]   [Full Text] [Related]  

  • 35. A correlation of EEG, reticular multiple unit activity and gross behavior following various antidepressant agents in the cat. IV.
    Wallach MB; Winters WD; Mandell AJ; Spooner CE
    Electroencephalogr Clin Neurophysiol; 1969 Dec; 27(6):563-73. PubMed ID: 4188780
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of paroxetine on human sleep.
    Oswald I; Adam K
    Br J Clin Pharmacol; 1986 Jul; 22(1):97-9. PubMed ID: 2943309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressants and the serotonin uptake in platelets.
    Lingjaerde O
    Acta Psychiatr Scand Suppl; 1980; 280():111-9. PubMed ID: 6996427
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacokinetics of paroxetine in renal impairment.
    Doyle GD; Laher M; Kelly JG; Byrne MM; Clarkson A; Zussman BD
    Acta Psychiatr Scand Suppl; 1989; 350():89-90. PubMed ID: 2530798
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).
    Itil TM; Polvan N; Hsu W
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):395-413. PubMed ID: 4625520
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of tricyclic antidepressants on the somatosensory evoked potential in man.
    Saletu B; Saletu M; Itil TM
    Psychopharmacologia; 1973 Feb; 29(1):1-12. PubMed ID: 4695204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.